🇺🇸 FDA

Intelligence Platform

Patents

Browse 89 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9120872

Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic poly

REGENTIS BIOMATERIALS LTD. · Granted Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9114146

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9114145

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9012434

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9006222

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8993549

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8993548

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8987238

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8987237

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8933059

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846649

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846648

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822218

Method of generating natural killer cells and dendritic cells from human embryonic stem ce

Stem Cell & Regenerative Medicine International · Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8765141

Development of a marker foot and mouth disease virus vaccine candidate that is attenuated

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8633178

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8501247

Pest control using natural pest control agent blends

TYRATECH, INC. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8173392

In vivo incorporation of unnatural amino acids

The Regents of the University of California · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8114648

In vivo incorporation of unnatural amino acids

The Regents of the University of California · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088604

Production of defined monodisperse heparosan polymers and unnatural polymers with polysacc

The Board of Regents of the University of Oklahoma · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030074

In vivo incorporation of unnatural amino acids

The Regents of the University of California · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8007774

Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic poly

REGENTIS BIOMATERIALS LTD. · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915025

In vivo incorporation of unnatural amino acids

The Regents of the University of California · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7893224

Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase

Alnylam Pharmaceuticals, Inc. · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7842667

Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic poly

REGENTIS BIOMATERIALS LTD. · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted